Remarkably, WSB2 mRNA levels were significantly elevated in multiple cancers, including prostate adenocarcinoma (PRAD) and liver hepatocellular carcinoma (LIHC), compared to corresponding normal tissues (Figure 7A). The gene discussed is WSB2; the disease is prostate adenocarcinoma.